The forecasted import of vaccines for human use to Saudi Arabia indicates consistent year-on-year growth. Values standing at 669.51 thousand kg in 2024 are projected to increase by approximately 1.65% annually, reaching 712.47 thousand kg by 2028. In comparison to the actual figures for 2023, the data reflects a steady upward trend driven by increasing public health initiatives and growing immunization needs.
Year-on-Year variations:
- 2024-2025: 1.65%
- 2025-2026: 1.59%
- 2026-2027: 1.54%
- 2027-2028: 1.49%
The five-year CAGR stands at 1.57%, suggesting a gradual but reliable increase in vaccine imports. This trend may be influenced by factors such as population growth, government health policies, and potential outbreaks necessitating increased vaccine supplies.
Future trends to watch for include potential advancements in vaccine technology, changes in global production and supply chain dynamics, and shifts in Saudi Arabia’s healthcare policy which could impact the import volume and growth rate moving forward.
